143 related articles for article (PubMed ID: 30453389)
1. Hypothyroidism is associated with worse outcomes of hepatocellular carcinoma patients after liver transplantation.
Zhang N; Jin W; Zhou S; Yang JD; Harmsen WS; Giama NH; Wongjarupong N; Heimbach JK; Watt KD; Malhi H; Therneau TM; Roberts LR
Cancer Med; 2018 Dec; 7(12):5870-5878. PubMed ID: 30453389
[TBL] [Abstract][Full Text] [Related]
2. Post-transplant infection improves outcome of hepatocellular carcinoma patients after orthotopic liver transplantation.
Chao JS; Zhao SL; Ou-Yang SW; Qian YB; Liu AQ; Tang HM; Zhong L; Peng ZH; Xu JM; Sun HC
World J Gastroenterol; 2019 Oct; 25(37):5630-5640. PubMed ID: 31602163
[TBL] [Abstract][Full Text] [Related]
3. Salvage Liver Transplantation Leads to Poorer Outcome in Hepatocellular Carcinoma Compared with Primary Liver Transplantation.
Shan Y; Huang L; Xia Q
Sci Rep; 2017 Mar; 7():44652. PubMed ID: 28294176
[TBL] [Abstract][Full Text] [Related]
4. Incidental hepatocellular carcinoma: risk factors and long-term outcome after liver transplantation.
Senkerikova R; Frankova S; Sperl J; Oliverius M; Kieslichova E; Filipova H; Kautznerova D; Honsova E; Trunecka P; Spicak J
Transplant Proc; 2014 Jun; 46(5):1426-9. PubMed ID: 24935308
[TBL] [Abstract][Full Text] [Related]
5. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality.
Serper M; Taddei TH; Mehta R; D'Addeo K; Dai F; Aytaman A; Baytarian M; Fox R; Hunt K; Goldberg DS; Valderrama A; Kaplan DE;
Gastroenterology; 2017 Jun; 152(8):1954-1964. PubMed ID: 28283421
[TBL] [Abstract][Full Text] [Related]
6. [Experience of the treatment following downstaging of larger hepatocellular carcinomas by transcathetheter hepatic arterial chemoembolization in 58 patients].
Jin X; Shi XJ; Wang MQ; Wei LX; Ye HY; Liang YR; Luo Y; Dong JH
Zhonghua Yi Xue Za Zhi; 2011 Apr; 91(14):950-5. PubMed ID: 21609544
[TBL] [Abstract][Full Text] [Related]
7. Association between donor and recipient smoothened gene polymorphisms and the risk of hepatocellular carcinoma recurrence following orthotopic liver transplantation in a Han Chinese population.
Wang P; Song W; Li H; Wang C; Shi B; Guo W; Zhong L
Tumour Biol; 2015 Sep; 36(10):7807-15. PubMed ID: 25944162
[TBL] [Abstract][Full Text] [Related]
8. Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial.
Geissler EK; Schnitzbauer AA; Zülke C; Lamby PE; Proneth A; Duvoux C; Burra P; Jauch KW; Rentsch M; Ganten TM; Schmidt J; Settmacher U; Heise M; Rossi G; Cillo U; Kneteman N; Adam R; van Hoek B; Bachellier P; Wolf P; Rostaing L; Bechstein WO; Rizell M; Powell J; Hidalgo E; Gugenheim J; Wolters H; Brockmann J; Roy A; Mutzbauer I; Schlitt A; Beckebaum S; Graeb C; Nadalin S; Valente U; Turrión VS; Jamieson N; Scholz T; Colledan M; Fändrich F; Becker T; Söderdahl G; Chazouillères O; Mäkisalo H; Pageaux GP; Steininger R; Soliman T; de Jong KP; Pirenne J; Margreiter R; Pratschke J; Pinna AD; Hauss J; Schreiber S; Strasser S; Klempnauer J; Troisi RI; Bhoori S; Lerut J; Bilbao I; Klein CG; Königsrainer A; Mirza DF; Otto G; Mazzaferro V; Neuhaus P; Schlitt HJ
Transplantation; 2016 Jan; 100(1):116-25. PubMed ID: 26555945
[TBL] [Abstract][Full Text] [Related]
9. Effect of body mass index on survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Takeda H; Sakamoto A; Saito S; Nishijima N; Nasu A; Arimoto A; Kita R; Kimura T
J Gastrointestin Liver Dis; 2013 Jun; 22(2):173-81. PubMed ID: 23799216
[TBL] [Abstract][Full Text] [Related]
10. Outcome of ABO-incompatible adult living-donor liver transplantation for patients with hepatocellular carcinoma.
Yoon YI; Song GW; Lee SG; Hwang S; Kim KH; Kim SH; Kang WH; Cho HD; Jwa EK; Kwon JH; Tak EY; Kirchner VA
J Hepatol; 2018 Jun; 68(6):1153-1162. PubMed ID: 29452208
[TBL] [Abstract][Full Text] [Related]
11. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
12. Effects of maintenance immunosuppression with sirolimus after liver transplant for hepatocellular carcinoma.
Yanik EL; Chinnakotla S; Gustafson SK; Snyder JJ; Israni AK; Segev DL; Engels EA
Liver Transpl; 2016 May; 22(5):627-34. PubMed ID: 26784951
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of locoregional therapy before living donor liver transplantation in patients with hepatocellular carcinoma who meet the Milan criteria.
Kim JM; Kwon CH; Joh JW; Choi MS; Lee JH; Koh KC; Paik SW; Kim GS; Kim SJ; Lee SK; Yoo BC
Transplant Proc; 2012 Mar; 44(2):403-8. PubMed ID: 22410028
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Salvage Liver Transplantation and Re-resection/Radiofrequency Ablation for Intrahepatic Recurrent Hepatocellular Carcinoma: A New Surgical Strategy Based on Recurrence Pattern.
Zhang X; Li C; Wen T; Peng W; Yan L; Yang J
Dig Dis Sci; 2018 Feb; 63(2):502-514. PubMed ID: 29238896
[TBL] [Abstract][Full Text] [Related]
15. Serum alpha-fetoprotein level independently predicts posttransplant survival in patients with hepatocellular carcinoma.
Berry K; Ioannou GN
Liver Transpl; 2013 Jun; 19(6):634-45. PubMed ID: 23536495
[TBL] [Abstract][Full Text] [Related]
16. The Effect of Bridging Locoregional Therapy and Sociodemographics on Survival in Hepatocellular Carcinoma Patients Undergoing Orthotopic Liver Transplantation: A United Network for Organ Sharing Population Study.
Magnetta MJ; Xing M; Zhang D; Kim HS
J Vasc Interv Radiol; 2016 Dec; 27(12):1822-1828. PubMed ID: 27692856
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of the HALT-HCC score to predict mortality in liver transplant recipients with hepatocellular carcinoma: a retrospective cohort analysis.
Sasaki K; Firl DJ; Hashimoto K; Fujiki M; Diago-Uso T; Quintini C; Eghtesad B; Fung JJ; Aucejo FN; Miller CM
Lancet Gastroenterol Hepatol; 2017 Aug; 2(8):595-603. PubMed ID: 28546007
[TBL] [Abstract][Full Text] [Related]
18. Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study.
Habibollahi P; Shamchi SP; Choi JM; Gade TP; Stavropoulos SW; Hunt SJ; Dagli M; Sudheendra D; Mondschein JI; Soulen MC; Nadolski GJ
J Vasc Interv Radiol; 2019 Mar; 30(3):323-329. PubMed ID: 30819472
[TBL] [Abstract][Full Text] [Related]
19. Hypothyroidism: a possible risk factor for liver cancer in patients with no known underlying cause of liver disease.
Reddy A; Dash C; Leerapun A; Mettler TA; Stadheim LM; Lazaridis KN; Roberts RO; Roberts LR
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):118-23. PubMed ID: 17008133
[TBL] [Abstract][Full Text] [Related]
20. Antiviral therapy improves post-operative survival outcomes in patients with HBV-related hepatocellular carcinoma of less than 3 cm - A retrospective cohort study.
Wang ZY; Tao QF; Wang ZH; Lin KY; Huang G; Yang Y; Zhou WP; Lau WY
Am J Surg; 2020 Apr; 219(4):717-725. PubMed ID: 31266631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]